Donald E. Kiernan

Health Management Associates, Inc. through its subsidiaries owns and operates general acute care hospitals and other health care facilities in non-urban communities. The company provides various health services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care and pediatric services and also provides out patient services, such as one-day surgery, laboratory, x-ray, respiratory therapy, cardiology and physical therapy, cardiology, neuro-surgery, oncology, radiation therapy, computer-assisted tomography scanning, magnetic resonance imaging, lithotripsy and full-service obstetrics. The company was founded by Joseph Greene, Richard Schnatter, Jeff Jones and James Cheek in September 1977 and is headquartered in Naples, FL.

SBC Communications, Inc. provides telecommunications services primarily in the United States. It offers various services and products, such as local exchange services, wireless communications, long-distance services, Internet services, telecommunications equipment, and directory advertising and publishing services. The company provides landline telecommunications services, such as local, long-distance voice, switched access, data and messaging services, and satellite television services; mobile wireless voice and data communications services; and directory services, such as advertising, Yellow and White Pages directories, and electronic directory publishing

LaBranche & Co., Inc. provides securities execution and brokerage services to institutional investors and professional traders. The company was founded by George M.L. LaBranche Jr. in 1924 and is headquartered in New York, NY.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies